Noonan syndrome (NS) is an autosomal dominant disorder caused by mutations in PTPN11, KRAS, SOS1, and RAF1 We performed SOS1, RAF1, BRAF MEK1, and MEK2 mutation analysis in a cohort of 102 PTPN11- and KRAS-negative NS patients and found pathogenic SOS1 mutations in 10, RAF1 mutations in 4, and BRAF mutations in 2 patients. Three novel SOS1 mutations were found. One was classified as a rare benign variant and the other remains unclassified. We confirm a high prevalence of pulmonic stenosis and ectodermal abnormalities in SOS1-positive patients. Three patients with SOS1 mutations presented with tumors (embryonal rhabdomyosarcoma, Sertoli cell testis tumor, and granular cell tumors of the skin). One patient with a RAF1 mutation had a lesion suggestive for a giant cell tumor. This is the first report describing different tumor types in ISIS patients with germ line SOS1 mutations. (C) 2009 Wiley-Liss, Inc.
Cremers, Int J Pediatr Otorhinolaryngol, 23, 81 (1992)
Digilio, Am J Hum Genet, 71, 389 (2002)
Emuss, Cancer Res, 65, 9719 (2005)
Estep Anne L., Tidyman William E., Teitell Michael A., Cotter Philip D., Rauen Katherine A., HRAS mutations in Costello syndrome: Detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy, 10.1002/ajmg.a.31078
Flotho C, Valcamonica S, Mach-Pascual S, Schmahl G, Corral L, Ritterbach J, Hasle H, Aricò M, Biondi A, Niemeyer CM, RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML), 10.1038/sj.leu.2401240
Fryssira, Eur J Pediatr, 167, 1025 (2008)
Ijiri, Pediatr Radiol, 30, 432 (2000)
Jung, J Pediatr Hematol Oncol, 25, 330 (2003)
Khan, J Med Genet, 32, 743 (1995)
Kratz, Blood, 106, 2183 (2005)
Lee, Int J Pediatr Dent, 15, 140 (2005)
Legius, J Med Genet, 39, 571 (2002)
Lohmann, Clin Dysmorphol, 9, 301 (2000)
Lopez-Miranda, Pediatr Radiol, 27, 324 (1997)
Malumbres, Nat Rev Cancer, 3, 459 (2003)
Martin, Arch Dermatol, 126, 1051 (1990)
Moschovi, J Pediatr Hematol Oncol, 29, 341 (2007)
Naficy, Otolaryngol Head Neck Surg, 116, 265 (1997)
Nava, J Med Genet, 44, 763 (2007)
Neumann, Eur J Hum Genet, 17, 420 (2009)
Niihori, Nat Genet, 38, 294 (2006)
Pandit, Nat Genet, 39, 1007 (2007)
Qiu, Otolaryngol Head Neck Surg, 118, 319 (1998)
Razzaque, Nat Genet, 39, 1013 (2007)
Roberts, Nat Genet, 39, 70 (2007)
Rodriguez-Viciana, Science, 311, 1287 (2006)
Sahn, J Am Acad Dermatol, 36, 327 (1997)
Sarkozy, Eur J Hum Genet, 12, 1069 (2004)
Sarkozy, Hum Mutat, 30, 695 (2009)
Schrader, Clin Genet, 75, 185 (2009)
Schubbert, Nat Genet, 38, 331 (2006)
Swanson, Genes Chromosomes Cancer, 47, 253 (2008)
Tartaglia, Nat Genet, 29, 465 (2001)
Tartaglia, Am J Hum Genet, 70, 1555 (2002)
Tartaglia, Am J Hum Genet, 78, 279 (2006)
Tartaglia, Nat Genet, 39, 75 (2007)
Tidyman, Curr Opin Genet Dev, 19, 230 (2009)
Tonsgard, Semin Pediatr Neurol, 13, 2 (2006)
Weber-Hall, Cancer Res, 56, 3220 (1996)
Zebisch, Cancer Res, 66, 3401 (2006)
Zenker, J Pediatr, 144, 368 (2004)
Zenker, J Med Genet, 44, 651 (2007)
Zenker, J Med Genet, 44, 131 (2007)
Bibliographic reference
Denayer, Ellen ; Devriendt, Koen ; de Ravel, Thomy ; Van Buggenhout, Griet ; Smeets, Eric ; et. al. Tumor Spectrum in Children With Noonan Syndrome and SOS1 or RAF1 Mutations. In: Genes, Chromosomes & Cancer, Vol. 49, no. 3, p. 242-252 (2010)